Company Deep Dive
Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.
NUTX
Strong BuyAPPROVENutex Health Inc. · Healthcare · United States · $1.3B · Avg Vol: $28M/d
Nutex Health demonstrates exceptional financial velocity with 3,100% net income growth and an active buyback program, signaling management's strong confidence. As a provider of essential healthcare services, it remains insulated from broader cyclical industrial pressures and offers a clear, scalable model that is currently being mispriced by the market despite its explosive fundamental improvement.
COMPANY DESCRIPTION
Nutex Health Inc. operates a national network of micro-hospitals, primary care clinics, and independent physician associations, providing integrated healthcare services. Its focus on smaller, community-based micro-hospitals and value-based care models differentiates it in a fragmented healthcare market. The company is a niche player in micro-hospital development, pursuing a capital-efficient expansion strategy.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 219.3M | 247.6M | 479.9M | 875.3M | 58.6% | 846.7M | 869.7M | 965.3M | 5.0% |
| EPS | -100.50 | -10.50 | 10.25 | 11.13 | 8.6% | 25.79 | 28.30 | 28.83 | 60.9% |
| Shares | 4.3M | 4.5M | 5.5M | 7.1M | +63.5% | 6.8M | — | — | — |
| Debt | 267.2M | 275.8M | 340.3M | 351.4M | 9.6% | 347.3M | — | — | — |
| Equity | 95.9M | 61.5M | 132.4M | 329.4M | 50.9% | — | — | — | — |
| Op CF | 50.6M | 1.3M | 23.2M | 248.1M | 69.9% | 279.6M | — | — | — |
| Inv CF | -4.3M | -11.2M | -5.6M | -5.2M | — | — | — | — | — |
| Fin CF | -48.1M | -2.3M | 1.1M | -97.9M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NUTX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| NUTX | Nutex Health Inc.(you) | $1.3B | 99 | Strong Buy |
| AMN | AMN Healthcare Services, Inc. | $1.3B | 96 | Strong Buy |
| HCSG | Healthcare Services Group, Inc. | $1.6B | 95 | Strong Buy |
| MD | Pediatrix Medical Group, Inc. | $2.2B | 98 | Strong Buy |
| ARDT | Ardent Health, Inc. | $1.6B | 86 | Strong Buy |
| ADUS | Addus HomeCare Corporation | $2.3B | 92 | Strong Buy |
| AVAH | Aveanna Healthcare Holdings Inc. | $3.0B | 95 | Strong Buy |
| ASTH | Astrana Health, Inc. | $1.9B | 84 | Strong Buy |
| GRDN | Guardian Pharmacy Services, Inc. | $2.4B | 87 | Strong Buy |
| NHC | National HealthCare Corporation | $3.6B | 91 | Strong Buy |
Peer medians: ROE -25.8% · P/E 29.6x · Gross margin 58.8%